Breast Cancer Survivor Helps Launch Research Study

BCS_Blog_DTOP_BelowTitle_336x280

Woman launches study on breast cancer hormone regimen. Photo: James Woodcock/Billings Gazette

Chemotherapy, radiation therapy and surgery are often the most publicized treatment options for women with breast cancer. However, there are also hormone regimens that some people are prescribed to help limit the chance of a recurrence of this form of cancer. According to the Billings Gazette, Deb Meyers was given the drug Femara to reduce her risk of a second bout of breast cancer, yet the side effects were too hard to bare.

Myers, age 59, is a trained nurse, an active hiker and a fly-fisher. However, even she wasn't able to overcome the side effects caused by Femara, and eventually her doctor prescribed her another medicine called Tamoxifen.

When Myers was diagnosed with breast cancer, the community rallied around her and raised money for her medical expenses, but she felt the funds could be used for a greater cause. She approached the Billings Clinic in Montana about underwriting a nurse-led research study to evaluate the effects of the Femara hormone regimen on the quality of breast cancer survivors' lives.

According to the source, the study is now in the planning stage and will feature 100 postmenopausal breast cancer patients.

"It's about women helping each other and making a difference," Kathy Wilkinson, manager of cancer research at Billings Clinic, told the Billings Gazette.

Lockerdome BCS – desktop
Medianet BCS
The Breast Cancer Site is a place where supporters and survivors come together to help fight breast cancer. In addition to sharing personal stories of hope, shopping for the cause, and signing petitions, visitors can take just a moment each day to click on a pink button to provide free mammograms for women in need. Visit The Breast Cancer Site and click today - it's free!